Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
VP1–141 is a determinant of a Vero cell-adapted Coxsackievirus A10 for vaccine development
Saved in:
| Published in: | PLoS Neglected Tropical Disease |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: VP1–141 is a determinant of a Vero cell-adapted Coxsackievirus A10 for vaccine development
- Multi-epitope mRNA vaccine and protein vaccine protect mice against
- Influenza vaccine hesitancy among healthcare workers in a university hospital in Turkiye: a cross-sectional study
- Safety of BNT162b2 COVID-19 Vaccine in Pregnancy: A Systematic Review
- Prevalence and risk factors of hepatitis B vaccine non-response in hemodialysis patients: a narrative review
- Maternal Group B Streptococcus Vaccination: A Three-Country European Consortium to Improve Surveillance and Data Readiness
- Accelerating vaccine research and development for skin neglected tropical diseases: A case for leishmaniasis, leprosy, and Buruli ulcer